Back to Agenda
Session 9 Track 3: Beyond the MSL: Build Compliant and Collaborative Field Medical Support for Market Access
Session Chair(s)
Iris Tam, PharmD
Senior Vice President and Head, Medical Affairs and HEOR
COEUS, United States
Market Access teams are under pressure to demonstrate value to payers, yet the industry’s reflex remains: “Send in the MSL.” Those who’ve worked in payer engagement know this misses the mark. Payers require scientific dialogue that connects evidence to access, the kind delivered by specialized field medical experts such as Managed Care Liaisons (MCLs) and Health Outcomes Liaisons (HOLs).
For Medical Affairs leaders, this is a pivotal and often underleveraged opportunity. By strategically aligning with Market Access colleagues, Medical Affairs can strengthen credibility, accelerate access, and fill genuine business needs, all while operating compliantly across the “firewall.” This session explores how forward-thinking Medical Affairs organizations are redefining their field strategies to bridge science and access, elevate payer engagement, and become indispensable partners to their Market Access counterparts.
Through case examples, panel dialogue, and decades of field experience, participants will learn how to evolve their Medical Affairs field model to deliver both scientific excellence and tangible access impact.
Learning Objective : - Recognize the strategic opportunity for Medical Affairs to partner with Market Access through compliant collaboration that advances payer engagement and evidence translation
- Differentiate between therapeutic MSL roles and payer-facing Field Medical functions in purpose, execution, and impact
- Illustrate real-world examples of successful cross-functional partnership between Medical Affairs, HEOR, and Market Access
Speaker(s)
Speaker
Representative Invited
Takeda, United States
Speaker
Representative Invited
Gilead, United States
Speaker
Jordana Wollmann, PharmD
AstraZeneca, United States
National Clinical Account Director
Have an account?